Home
Obsidian Therapeutics, Inc.

Obsidian Therapeutics, Inc. Market Share Analysis for May 2026

Join our fiercely committed team in developing transformative therapies for patients.

Health > Biotechnology and Pharmaceuticals

Domainobsidiantx.com

Year Founded2015

Employees51 - 200

Annual Revenue$15M - $25M

Obsidian Therapeutics, Inc.

Obsidian Therapeutics, Inc. (including company regionals)

obsidiantx.com

See more website traffic and engagement information

Obsidian Therapeutics, Inc. Revenue up to May 2026 is 15M - 25M

revenue generated by Obsidian Therapeutics, Inc. top domains

Obsidian Therapeutics, Inc. top domains revenue over 3 years

Revenue for Obsidian Therapeutics, Inc. top domains

obsidiantx.com15M - 25M

See more with Sales Intelligence

Total visits to Obsidian Therapeutics, Inc.'s top domains

Understand Obsidian Therapeutics, Inc. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

obsidiantx.com5.3K

See more with Sales Intelligence

Avg. visit duration in Obsidian Therapeutics, Inc.'s top domains

Analyze Obsidian Therapeutics, Inc. engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

obsidiantx.com00:00:33

See more with Sales Intelligence

Avg. pageviews on Obsidian Therapeutics, Inc.'s top domains

See how Obsidian Therapeutics, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

obsidiantx.com1.83

See more with Sales Intelligence

Obsidian Therapeutics, Inc. top competitors by domain

Top similar sites in May 2026, ranked by their affinity

lyell.comCompany NameLyell Immunopharma, Inc.Employees201 - 500HQUnited States, California, South San FranciscoAnnual revenue$10M - $15MTotal visits8.6KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Obsidian Therapeutics, Inc.

These are the website technologies, by industry, used by Obsidian Therapeutics, Inc. top domains

Conversion & Analytics (4)

Google Analytics

Widget (4)

Twemoji

Advertising (2)

DoubleClick

Audio Video Media (2)

Vimeo

More Technologies

10

See all

News & Signals from Obsidian Therapeutics, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsObsidian Therapeutics, Inc. receives financing of $350M in private placement financing.US-based Obsidian Therapeutics announced a definitive all-stock merger agreement with compatriot firm Galera Therapeutics (OTC: GRTX), concurrent with a USD 350 million private placement financing, to advance its engineered tumor-infiltrating lymphocyte (TIL) cell therapy pipeline in solid tumors.

NewsGaleratx merged with Obsidian Therapeutics, Inc. on Oct 1st '24.After initiating a wind-down more than 18 months ago and exploring liquidation, Galera Therapeutics has found a partner via a reverse merger with Obsidian Therapeutics that will take oncology-focused Obsidian public.

NewsObsidian Therapeutics, Inc. attends event American Association for Cancer Research Annual Meeting.Obsidian Therapeutics announces multiple presentations at the American Association for Cancer Research Annual Meeting.